BioNTech完成对CureVac的收购

投资观察
Dec 18, 2025

12月18日 - BioNTech SE宣布已完成对CureVac B.V.的收购,约86.75%的CureVac股份已被拍卖。CureVac将继续按照现有的业务流程运营,并将完成必要的分析,以确定未来的组织和投资组合结构。预计在2026年1月将强制收购剩余股份。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10